メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
東北大学 ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
プレス/メディア
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
佐藤 紀宏
助教
大学病院 (科・部等に属さない)
h-index
705
被引用数
13
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2008
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(50)
プレス/メディア
(2)
類似のプロファイル
(6)
フィンガープリント
Toshihiro Satoが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Pharmacology, Toxicology and Pharmaceutical Science
Polypeptide
100%
Therapeutic Drug Monitoring
86%
Diseases
64%
Electrospray Ionization
61%
Biological Marker
57%
Clozapine
53%
Bile Acid
51%
Pharmacokinetics
41%
Liver Cell Carcinoma
37%
Lenvatinib
32%
Niemann Pick Disease
32%
Malignant Neoplasm
26%
CYP3A
23%
Protein Tyrosine Kinase Inhibitor
22%
Anticancer Drug
21%
Uremic Toxin
21%
Iron
20%
Treatment-Resistant Schizophrenia
20%
Sunitinib
20%
Organic Anion Transporter
19%
Rapamycin
18%
Drug Concentration
18%
Crizotinib
17%
Lithocholic Acid
17%
Sulfate
17%
Active Metabolite
17%
Drug Interaction
17%
Multiple Sclerosis
16%
Metformin
16%
Molecular Target
16%
Sunitinib
16%
Active Metabolite
16%
Anticarcinogen
16%
Nutrition Supplement
16%
Sphingosylphosphorylcholine
16%
Propofol
16%
CYP2B6
16%
CYP3A4
16%
Gefitinib
16%
Protein Disulfide Isomerase
16%
Estrogen Receptor Antagonist
16%
Curcumin
16%
Cyclin Dependent Kinase 4
16%
Cyclin Dependent Kinase 6
16%
Nonalcoholic Fatty Liver
16%
Ouabain
16%
Lactic Acid
16%
Protein P53
16%
Diabetic Nephropathy
16%
Digoxin
16%
Biochemistry, Genetics and Molecular Biology
Tandem Mass Spectrometry
76%
Liquid Chromatography-Mass Spectrometry
70%
Blood Plasma
67%
Metabolite
62%
Cell Proliferation
50%
Insulin Release
36%
S-Nitrosylation
32%
Protein Disulfide-Isomerase
32%
Optogenetics
32%
Electrospray Ionization
32%
Electrospray Ionization
28%
Blood Level
23%
Collision-Induced Dissociation
23%
Anticancer
21%
Pharmacokinetics
21%
Sunitinib
18%
Clozapine
18%
Sunitinib
16%
Gluconeogenesis
16%
Ibrutinib
16%
Bosutinib
16%
Oxidative Stress
16%
Mass Spectrometry
16%
Adenosine Monophosphate
16%
Dasatinib
16%
CYP2B6
16%
Cell Membrane
16%
Phosphotransferase
16%
Kinase
16%
CYP3A4
16%
Genotyping
16%
C2C12
16%
Propofol
16%
UGT1A9
16%
Insulin-Like Growth Factor 1
16%
Retrospective Study
16%
Glutathione
16%
Nilotinib
16%
Imatinib
16%
Comorbidity
16%
Cyclin-Dependent Kinase 6
16%
Aromatase Inhibitor
16%
Cyclin-Dependent Kinase 4
16%
Receptor Antagonist
16%
Estrogen Receptor
16%
Proteomics
16%
Niemann-Pick Disease
16%
Metabolomics
16%
Bile Acid
16%
Drug Concentration
16%
Medicine and Dentistry
Active Metabolite
32%
Sunitinib
32%
Peritoneal Dialysis
32%
Malignant Neoplasm
23%
Bile Acid
21%
Iron
20%
Tandem Mass Spectrometry
20%
Anticarcinogen
19%
Metabolite
19%
Hepatocellular Carcinoma
19%
Tandem Mass Spectrometry
18%
Choline
18%
Biological Marker
18%
Diabetic Nephropathy
17%
Parturition
16%
Electrospray Ionization
16%
Analysis
16%
Plasma
16%
Flurothyl
16%
Gefitinib
16%
Protein P53
16%
Pulmonary Surfactant
16%
Mesenchymal-Epithelial Transition
16%
Alveolar Cell
16%
Pancreas Cancer
16%
Long Term Exposure
16%
Gut Microbiome
16%
Electrospray Ionization
16%
Albuminuria
16%
Iron Chelating Agent
16%
Ferric Ion
16%
Prospective Study
16%
Peritonitis
16%
Insulin Dependent Diabetes Mellitus
16%
Nivolumab
16%
COVID-19 Vaccination
16%
Phagocytosis
16%
Macrophage
16%
Prospective Cohort Study
16%
Lung
16%
Egg Lecithin
16%
Nonalcoholic Fatty Liver
16%
Sulfate
16%
Anticancer Drug
16%
Targeted Metabolomics
16%
Liquid Chromatography-Mass Spectrometry
16%
Analgesic Efficacy
16%
Ropivacaine
16%
Minimally Invasive Cardiac Surgery
16%
Infusion
16%
